NewAmsterdam Pharma
Pre-clinicalWe're advancing a new era of treatment for cardiovascular disease and other lipid-related conditions.
Founded
2019
Focus
Small Molecules
About
We're advancing a new era of treatment for cardiovascular disease and other lipid-related conditions.
Funding History
2Total raised: $346M
Series B$150MForbionMar 15, 2022
Series A$196MForbionDec 15, 2020
Company Info
TypePrivate
Founded2019
LocationNaarden, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile